Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

Hangzhou Biotest Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,765	3,452	3,229	4,928	7,456	-
Market Cap Growth	74.39%	6.92%	-34.48%	-33.91%	-	-
Enterprise Value	4,243	1,845	1,370	2,774	5,736	-
Last Close Price	39.40	22.73	20.21	28.71	41.65	-
PE Ratio	60.30	20.36	30.29	6.37	8.94	-
PS Ratio	12.04	6.17	7.30	2.59	4.10	-
PB Ratio	2.46	1.43	1.33	1.92	3.54	-
P/TBV Ratio	2.79	1.62	1.46	2.10	3.57	-
P/FCF Ratio	409.11	-	43.08	9.40	10.53	-
P/OCF Ratio	61.41	26.80	24.58	7.01	8.21	-
EV/Sales Ratio	8.86	3.30	3.10	1.46	3.16	-
EV/EBITDA Ratio	70.01	13.77	47.44	3.59	5.92	-
EV/EBIT Ratio	104.64	16.36	325.74	3.69	5.97	-
EV/FCF Ratio	301.12	-	18.28	5.29	8.10	-
Debt / Equity Ratio	0	0	0.00	0.00	0.01	0.03
Debt / EBITDA Ratio	0.00	0.00	0.09	0.01	0.01	0.02
Debt / FCF Ratio	0.01	-	0.04	0.02	0.02	0.03
Asset Turnover	0.19	0.22	0.17	0.73	1.19	2.05
Inventory Turnover	3.39	3.32	2.30	6.79	6.03	3.77
Quick Ratio	12.91	9.81	13.27	12.16	5.93	1.93
Current Ratio	13.66	10.51	13.97	13.07	6.40	2.46
Return on Equity (ROE)	4.26%	6.90%	4.23%	33.13%	65.52%	152.90%
Return on Assets (ROA)	1.01%	2.72%	0.10%	18.15%	39.19%	77.90%
Return on Invested Capital (ROIC)	4.37%	15.22%	0.74%	140.06%	283.49%	263.93%
Return on Capital Employed (ROCE)	1.70%	4.70%	0.20%	29.20%	45.50%	118.70%
Earnings Yield	1.78%	4.91%	3.30%	15.70%	11.18%	-
FCF Yield	0.24%	-3.37%	2.32%	10.64%	9.50%	-
Dividend Yield	2.62%	4.71%	2.83%	5.47%	5.15%	-
Payout Ratio	157.54%	49.34%	220.13%	41.37%	2.51%	23.07%
Buyback Yield / Dilution	-6.66%	1.23%	0.10%	-23.14%	-8.33%	0.01%
Total Shareholder Return	-3.99%	5.95%	2.93%	-17.67%	-3.18%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.